Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Charles River Labs in $300M stock repurchase program

August 27, 2010 6:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Charles River Laboratories International Inc., a Wilmington provider of outsourced laboratory and research services, has begun an accelerated stock repurchase program to buy back $300 million worth of common stock.

Specialty Surgical Instrumentation Launches New Interactive Web Site

August 27, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Aug. 27 /- Specialty Surgical Instrumentation, Inc. (SSI) a division of Symmetry Medical Inc. (NYSE: SMA ) and leading provider of surgical instruments and sterilization products, announced today the launch of a new interactive, e-commerce Web site at www.specsurg.com ....

TOPICS:

Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

August 27, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Aug. 27 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced that on August 25, 2010 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options...

TOPICS:
Advertisement

Novartis receives FDA approval of Tekamloâ„¢, a single-pill combination of aliskiren and amlodipine to treat high blood pressure

August 27, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

EAST HANOVER, N.J., Aug. 27 /- The US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used...

TOPICS:

Shire Announces European Approval of VPRIV & #174; (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease

August 27, 2010 6:33 am | by RealWire | News | Comments

Cambridge, MA, US - August, 27th 2010 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV® (velaglucerase alfa), a human cell line derived enzyme replacement...

TOPICS:

Landauer, Inc. Declares Regular Cash Dividend

August 27, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

GLENWOOD, Ill., Aug. 27 /- Landauer, Inc. (NYSE: LDR ) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.5375 per share for the fourth quarter of fiscal 2010.  The dividend will be paid on October 2, 2010, to shareholders of record on...

TOPICS:

USB Interface for Surge Test Equipment

August 27, 2010 6:29 am | Compliance West USA | Product Releases | Comments

Compliance West USA announces the Defib-5P, the first defib-proof tester on the market utilizing USB connectivity. The feature set of the USB Interface allows for increased flexibility in test setups...

Innovnano announces the construction of a new nanomaterials plant

August 26, 2010 11:33 pm | by I-Micronews | News | Comments

Innovnano presented a project for the construction of a new plant for the synthesis of nanomaterials.

Advertisement

Nanocomp Technologies awarded phase II critical SBIR contract by United States air force

August 26, 2010 10:32 pm | by I-Micronews | News | Comments

Program Works to Scale Up Production, Optimize Properties of Large-Format Carbon Nanotube Sheets for Future Use in Manned and Unmanned Aircraft

Nanophase Technologies and Altana AG enter into new supply agreement

August 26, 2010 10:32 pm | by I-Micronews | News | Comments

ROMEOVILLE, Ill., Nanophase Technologies Corporation, a technology leader in nanomaterials and advanced nanoengineered products, announced today that Nanophase and its partner, the German specialty chemical company Altana AG (through its subsidiary BYK Chemie GmbH) have entered into a new...

GnuBIO acquires exclusive world wide rights to novel microfluidics and emulsion methodologies for DNA sequencing

August 26, 2010 10:32 pm | by I-Micronews | News | Comments

GnuBIO, a pioneer in scalable, solution-based, low cost DNA sequencing announced today that it has obtained an exclusive worldwide license for the use of microfluidics and emulsion based methodologies for nucleic acid analysis.

TOPICS:

Vaccine has cut child cases of bacterial pneumonia, says study

August 26, 2010 9:33 pm | by EurekAlert | News | Comments

(Imperial College London) The number of children admitted to English hospitals with bacterial pneumonia decreased by a fifth in the two years following the introduction of a vaccine to combat the disease, according to a new study published today in the journal Thorax.

TOPICS:

Diabetes impairs but does not halt sex among older adults

August 26, 2010 9:31 pm | by EurekAlert | News | Comments

(University of Chicago Medical Center) Many middle-aged and older adults with diabetes are sexually active, according to a new survey. Seventy percent of partnered men with diabetes and 62 percent of partnered women with diabetes engaged in sexual activity two or three times a month,...

TOPICS:

BCM pediatric cancer researchers get funding from St. Baldrick's Foundation

August 26, 2010 1:32 pm | by Baylor College of Medicine | News | Comments

Three Baylor College of Medicine physician-scientists have received support totaling more than $500,000 from St. Baldrick's Foundation to advance their research in pediatric cancer. Dr. Karen Rabin, assistant professor of pediatrics – hematology/oncology, was named a St. Baldrick's...

TOPICS:

Shire's Gaucher disease drug approved in Europe

August 26, 2010 12:36 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Shire plc has won approval from the European Commission to market its Gaucher disease treatment, called VPRIV, to 30 countries in Europe.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading